Kristin Ryan, Pharm.D. is excited to be representing Elevar Therapeutics at The Liver Meeting (AASLD) 2025 in Washington, D.C.! This is the premier global conference for liver disease research and innovation, and she's looking forward to connecting with leading clinicians, researchers, and industry partners to share the latest scientific advancements. Elevar is dedicated to developing novel therapies, particularly for patients with hepatocellular carcinoma (HCC), and this event is a fantastic opportunity to discuss how we can continue to elevate outcomes for patients. #TLM25 #ElevarTx #ElevarTherapeutics #Oncology
I’m rooting for you! You’ve got this!
Driving Marketing Success in Healthcare | Launch Excellence | Expansive Therapeutic Area Experience
1wIt was great reconnecting!